{"id":"tp-59376","type":"article-newspaper","title":"FDA Approves Roche’s Wilserdly Oral Breast Cancer Therapy","author":"Riza Dagoc","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/regulation/59376","datePublished":"2026-11-17T12:44:24.000Z","dateModified":"2026-11-17T12:44:24.000Z","language":"en","abstract":"The approval is the first of two U.S. regulatory decisions expected this year for the oral therapy.","section":"Regulation","references":[]}